Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes

Journal of Investigative Dermatology

Volumn 112, Issue 6, 1999, Pages 925-932

  Eberle, Jürgen ^a   Weitmann, Silke ^a   Thieck, Oliver ^a   Pech, Heidrun ^a   Paul, Martin ^a   Orfanos, Constantin E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Malignancy; Melanocytes; Nevus cells

Indexed keywords

ENDOTHELIN B RECEPTOR; MELANIN; MONOPHENOL MONOOXYGENASE; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA CELL; NEVUS CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033039244     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00598.x     Document Type: Article

References (47)

1. Aubert C, Rouge F, Galindo JR: Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J Natl Cancer Inst 64:1020-1040, 1980
2. Aubert C, Rouge F, Reillaudou M, Metge P: Establishment and characterization of human ocular melanoma cell lines. Int J Cancer 54:784-792, 1993
3. Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M: Interaction of endothelin-3 with endothelin B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277-1285, 1994
4. Bean MA, Bloom BR, Herberman RB, Old LJ, Oettgen HF, Klein G, Terry WD: Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res 35:2902-2913, 1975
5. Brüggen J, Sorg C, Macher E: Membrane associated antigens of human malignant melanoma V: serological typing of cell lines using antisera from nonhuman primates. Cancer Immunol Immunother 5:53-62, 1978
6. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ: Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 73:3278-3282, 1976
7. Eberle J, Krasagakis K, Garbe C, Orfanos CE: Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions. Melanoma Res 3:107-112, 1993
8. Eberle J, Garbe C, Kroumpouzos G, Orfanos CE: Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression. Recent Results Cancer Res 139:123-135, 1995a
9. Eberle J, Garbe C, Orfanos CE: Identification of genes specifically regulated in human melanoma cells. Arch Dermatol Res 287:421-427, 1995b
10. Eberle J, Garbe C, Wang N, Orfanos CE: Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res 8:307-313, 1995c
11. Eberle J, Krasagakis K, Orfanos CE: Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 71:396-401, 1997
12. Eberle J, Wagner M, MacNeil S: Human melanoma cell lines show little relationship between expression of pigmentation genes and pigmentary behaviour in vitro. Pigment Cell Res 11:134-142, 1998
13. Elshourbagy NA, Korman DR, Wu HL, et al: Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 268:3873-3879, 1993
14. Elshourbagy NA, Adamou JE, Gagnon AW, Wu HL, Pullen M, Nambi P: Molecular characterization of a novel human endothelin receptor splice variant. J Biol Chem 271:25300-25307, 1996
15. Gariepy CE, Cass DT, Yanagisawa M: Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93:867-872, 1996
16. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417-1423, 1973
17. Grant ES, Brown T, Roach A, Williams BC, Habib FK: In vitro expression of endothelin-1 (ET-1) and the EDNRA and ETB ET receptors by the prostatic epithelium and stroma. J Clin Endocrinol Mednrab 82:508-513, 1997
18. Halaban R, Langdon R, Birchall N, et al: Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 107:1611-1619, 1988
19. Hara M, Yaar M, Gilchrest BA: Endothelin-1 of keratinocyte origin is a mediator of melanocyte dendriciry. J Invest Dermatol 105:744-748, 1995
20. Hara M, Tozawa F, Itazaki K, Mihara S, Fujimoto M: Endothelin ET (B) receptors show different binding profiles in intact cells and cell membrane preparations. Eur J Pharmacol 345:339-342, 1998
21. Holzmann B, Lehmann JM, Ziegler-Heitbrock HW, Funke I, Riethmuller G, Johnson JP: Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen. Int J Cancer 41:542-547, 1988
22. Horikawa T, Norris DA, Yohn JJ, Zekman T, Travers JB, Morelli JG: Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 104:256-259, 1995
23. Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M: Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17:4358-4369, 1998
24. Imokawa G, Yada Y, Miyagishi M: Endothelins secreted from human keratinocytes are intrinsic mitogem for human melanocytes. J Biol Chem 267:24675-24680, 1992
25. Imokawa G, Miyagishi M, Yada Y: Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 105:32-37, 1995
26. Imokawa G, Yada Y, Kimura M: Signaling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem J 314:305-312, 1996
27. Imokawa G, Kobayashi T, Miyagishi M: Higashi K, Yada Y: The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res 10:218-228, 1997
28. Kikuchi K, Nakagawa H, Kadono T, Etoh T, Byers HR, Mihm MC, Tamaki K: Decreased ET(B) receptor expression in human metastatic melanoma cells. Biochem Biophys Res Commun 219:734-739, 1996
29. Liao SK, Dent PB, McCulloch PB: Characterization of human malignant melanoma cell lines. I. Morphology and growth characteristics in culture. J Natl Cancer Inst 54:1037-1044, 1975
30. Lockshin A, Giovanella BC, De Ipolyi PD, Williams LJ Jr, Mendoza JT, Yim SO, Stehlin JSJ: Exceptional lethality for nude mice of cells derived from a primary human melanoma. Cancer Res 45:345-350, 1985
31. McCallum FS, Maden BE: Human 18 S ribosomal RNA sequence inferred from DNA sequence. Variations in 18 S sequences and secondary modification patterns between vertebrates. Biochem J 232:725-733, 1985
32. Monge JC, Stewart DJ, Cernacek P: Differentiation of embryonal carcinoma cells to a neural or cardiomyocyte lineage is associated with selective expression of endothelin receptors. J Biol Chem 270:15385-15390, 1995
33. van Montone KT, Belle P, Elenitsas R, Elder DE; Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol 10:939-944, 1997
34. Nelson JB, Chan Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW: Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56:663-668, 1996
35. Nelson JB, Lee WH, Nguyen SH, et al: Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 57:35-37, 1997
36. Okazawa M, Shiraki T, Ninomiya H, Kobayashi S, Masaki T: Endothelin-induced apoptosis of A375 human melanoma cells. J Biol Chem 273:12584-12592, 1998
37. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A: A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266, 1994
38. Sakurai T, Yanagisawa M, Masaki T: Molecular characterization of endothelin receptors. Trends Phannacol Sci 13:103-108, 1992
39. Simonson MS, Dunn MJ: Cellular signaling by peptides of the endothelin gene family, FASEB J 4:2989-3000, 1990
40. de Vries JE, Spits H: Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. J Immunol 132:510-519, 1984
41. de Vries JE, Comain S, Rumke P: Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,. Int J Cancer 14:427-434, 1974
42. Yaar M, Gilchrest BA: Human melanocyte growth and differentiation: a decade of new data. J Invest Dermatol 97:611-617, 1991
43. Yada Y, Higuchi K, Imokawa G: Effects of endothelins on signal transduction and proliferation in human melanocytes. J Biol Chem 266:18352-18357, 1991
44. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279, 1991
45. Yohn JJ, Morelli JG, Walchak SJ, Rundell KB, Norris DA, Zamora MR: Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol 100:23-26, 1993
46. Yohn JJ, Smith C, Stevens T, et al: Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Commun 201:449-457, 1994
47. Ziegler-Heitbrock HW, Munker R, Johnson J, Petersmann I, Schmoeckel C, Riethmuller G: In vitro differentiation of human melanoma cells analyzed with monoclonal antibodies. Cancer Res 45:1344-1350, 1985